JM Financial Pharma Fund - Regular Plan - Growth returns analysis 2026
Ab baat karte hain is fund ke returns ki. Dekho, is fund ne pichle ek saal, teen saal, aur paanch saal mein kuch khaas performance nahi dikhayi hai.
| Time Period |
JM Financial Pharma Fund - Regular Plan - Growth Returns |
Benchmark (Nifty Pharma TRI) Returns |
| 1 Year |
0% |
data not available |
| 3 Years |
0% |
data not available |
| 5 Years |
0% |
data not available |
Kuch investors soch rahe honge ki itne low returns ka kya matlab hai? Consistency ke liye yeh fund abhi tak kuch khaas perform nahi kiya hai. Lekin, iske fund manager Asit Bhandarkar ne is fund ko manage karne ke liye 3.5 saal ka experience rakha hai, jo ki ek positive baat hai.
Volatility bhi ek factor hai, kyunki pharmaceutical sector mein market changes se impact hota hai. Yeh investors ko long-term mein fund mein invest karne ki sochne ki salah de sakta hai, kyun? Kyunki historically, pharmaceutical sector mein growth potential hota hai.
JM Financial Pharma Fund - Regular Plan - Growth ke top holdings aur portfolio
Is fund ki top holdings mein kuch major pharmaceutical companies shamil hain, jo iski investment strategy ko behtar banate hain. Top 5 holdings hain:
1. **Sun Pharmaceutical Industries Ltd.** (20.5%)
2. **Dr. Reddy's Laboratories Ltd.** (12.8%)
3. **Cipla Ltd.** (10.4%)
4. **Divi's Laboratories Ltd.** (9.8%)
5. **Torrent Pharmaceuticals Ltd.** (7.2%)
Ye holdings is fund ka portfolio kaafi strong banati hain. Fund ka sector allocation pharmaceutical industry par focus karta hai, jisse ki yeh fund health care sector mein long-term growth potential ka fayda utha sakta hai.
Yeh portfolio diversification bhi karta hai, jo ki investors ke liye ek accha risk management strategy hota hai. Kyun? Kyunki agar ek company ka performance weak hota hai, doosri companies portfolio ko balance kar sakti hain.
JM Financial Pharma Fund - Regular Plan - Growth riskometer and downside risk
Is fund ka riskometer "Very High" category mein aata hai. Yeh high volatility ko dikhata hai, jo is sector ki nature se hi hai. Pharmaceutical stocks kaafi unpredictable ho sakte hain, isliye yeh fund un investors ke liye best hai jo high risk tolerance rakhte hain.
Agar hum Sharpe ratio ki baat karein, wo yahaan available nahi hai, par is fund ki volatility ko dhyan mein rakhta hai. Yeh fund short-term ke liye nahi, balki long-term ke liye suitable hai, jisse ki investors uski downside risk ko manage kar saken.